SOURCE: Rx Safes, Inc.

Rx Safes, Inc.

January 21, 2016 08:30 ET

Rx Safes Announces Retention of The Ruth Group

Leading Boutique Healthcare IR Firm to Introduce Company to Investment Community

HENDERSON, NV--(Marketwired - Jan 21, 2016) - Rx Safes, Inc. (OTCQB: RXSF), a healthcare technology company and developer of autonomous fingerprint healthcare security products, today announced that the Company engaged The Ruth Group, a leading healthcare-focused strategic communications firm based in New York City, as its investor relations counsel.

"It was important for Rx Safes to partner with an investor relations firm that had a long and successful track record within the healthcare industry. We look forward to working with The Ruth Group to leverage their expertise and relationships in the industry as we take the next steps in introducing the company to the healthcare and investment community. We expect to secure a qualified investment banker in the very near future as we anticipate integrating our technology and products into frontline solutions to prevent unauthorized access to and diversion of controlled substances," commented Lorraine Yarde, CEO of Rx Safes, Inc.

The Ruth Group, led by Carol Ruth, provides investor and public relations counsel and services to a diverse group of innovative healthcare companies. Carol is a pioneer in the field and has built a reputation for providing clients with strategic communications advice and counsel across a breadth of issues. She has a strong track record working with a wide range of healthcare companies in all sub-sectors and stages of development. In 2010, Carol was recognized by IR Magazine as the recipient of the "Lifetime Achievement in Investor Relations" award. A full list of The Ruth Group's clients can be viewed at

"Our team is very excited to be working with Rx Safes, who we believe have a unique focus on the development of products and medical devices that secure controlled substances at the end user level. Rx Safes represents a market niche that has already garnered attention from potential healthcare investors and partners" stated Carol Ruth, President of The Ruth Group. 

About Rx Safes, Inc.

Rx Safes is a medical healthcare technology companies and an emerging leader in the personal and professional healthcare drug security market. Our products incorporate proprietary patented fingerprint technology to provide drug security and medical information solutions for use in homes and healthcare facilities. Prescription drug misuse, drug diversion, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create a necessary opportunity for Rx Safes to expand our reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. For more information, please visit

Forward-Looking Statements for RXSF:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Like us on Facebook at
Follow us on Twitter at

Contact Information

  • Investor Relations Contact:
    Tram Bui
    Email Contact